Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Essapen, Sharadah"'
Autor:
Clamp AR; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., James EC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: E.james@ucl.ac.uk., McNeish IA; Department of Surgery and Cancer, Imperial College London, London, UK., Dean A; Oncology, St John of God Hospital, Subiaco, WA, Australia., Kim JW; Department of Obstetrics and Gynecology, Seoul National University, Seoul, South Korea., O'Donnell DM; Cancer Trials Ireland, Dublin, Ireland., Gallardo-Rincon D; Department of Medical Oncology, Instituto Nacional de Cancerologia, Mexico City, Mexico., Blagden S; Department of Oncology, Churchill Hospital, University of Oxford, Oxford, UK., Brenton J; Li Ka Shing Centre, Cancer Research UK Cambridge Institute, Cambridge, UK., Perren TJ; Leeds Institute of Medical Research, St James' University Hospital, Leeds, UK., Sundar S; Institute of Cancer and Genomics, University of Birmingham, Birmingham, UK., Lord R; Department of Oncology, Clatterbridge Cancer Centre, Wirral, UK., Dark G; Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Hall M; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK., Banerjee S; Gynaecological Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK., Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, UK., Hanna CL; Department of Oncology, Velindre Cancer Centre, Cardiff, UK., Williams S; Birmingham City Hospital, Birmingham, UK., Scatchard KM; North Devon District Hospital, Barnstaple, UK; Exeter Oncology Centre, Royal Devon and Exeter Hospital, Exeter, UK., Nam H; Broomfield Hospital, Chelmsford, UK; Southend University Hospital, Southend, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK., Parkinson C; Cambridge Cancer Centre, Addenbrooke's Hospital, Cambridge, UK., McAvan L; Department of Oncology, University Hospital Coventry and Warwickshire, Coventry, UK., Swart AM; Norwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK., Popoola B; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Schiavone F; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Badrock J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Fananapazir F; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Parmar M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Kaplan R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute and UCL Hospitals, London, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Jul; Vol. 23 (7), pp. 919-930. Date of Electronic Publication: 2022 Jun 09.
Autor:
Morgan RD; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Cook AD; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., James EC; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Lord R; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK., Dark G; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, UK., Krell J; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Parkinson C; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Poole CJ; Arden Cancer Research Centre, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK., Hall M; Mount Vernon Cancer Centre, Northwood, UK., Gallardo-Rincón D; Instituto Nacional de Cancerología, Mexico City, Mexico., Lockley M; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Essapen S; Royal Surrey NHS Foundation Trust, Guildford, UK., Summers J; Maidstone and Tunbridge Wells NHS Trust, Kent, UK., Anand A; Nottingham University Hospitals NHS Trust, Nottingham, UK., Zachariah A; Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK., Williams S; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Jones R; South West Wales Cancer Centre, Singleton Hospital, Swansea, UK., Scatchard K; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Walther A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Kim JW; Seoul National University College of Medicine, Seoul, South Korea., Sundar S; Pan Birmingham Gynaecological Cancer Centre and University of Birmingham, Birmingham, UK., Jayson GC; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., Ledermann JA; UCL Hospitals NHS Foundation Trust and UCL Cancer Institute, London, UK., Clamp AR; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. Electronic address: andrew.clamp@christie.nhs.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Feb; Vol. 22 (2), pp. 277-288. Date of Electronic Publication: 2020 Dec 22.
Autor:
Iveson TJ; Southampton University Hospital NHS Foundation Trust, Southampton, UK. Electronic address: tim.iveson@uhs.nhs.uk., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Saunders MP; The Christie Hospital, Manchester, UK., Cassidy J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hollander NH; Department of Oncology and Palliative Care, Zealand University Hospital, Naestved, Denmark., Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Haydon A; Australasian Gastro-Intestinal Trials Group, Melbourne, VIC, Australia., Glimelius B; IGP, University of Uppsala, Uppsala, Sweden., Harkin A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Allan K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Scudder C; OCTO, University of Oxford, Department of Oncology, Oxford, UK., Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK., Briggs A; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK; Center for Health and Policy Outcomes, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Centre, New York, NY, USA., Waterston A; Beatson West of Scotland Cancer Centre, Glasgow UK., Medley L; Royal United Hospital, Bath, UK., Wilson C; Addenbrookes Hospital, Cambridge, UK., Ellis R; Royal Cornwall Hospital NHS Trust, Truro, UK., Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Dhadda AS; Castle Hill Hospital, Hull, UK., Harrison M; Mount Vernon Cancer Centre, Northwood, UK., Falk S; Bristol Cancer Institute, Bristol, UK., Raouf S; Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK., Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Olesen RK; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK., Bridgewater J; UCL Cancer Institute, University College London, London UK., Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Farrugia D; Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK., Webb A; Brighton and Sussex University Hospital Trust, Brighton, UK., Cunningham D; Royal Marsden Hospital, London, UK., Hickish T; Poole Hospital, Bournemouth University, Bournemouth, UK., Weaver A; Department of Oncology, Oxford University Hospitals Foundation Trust, Oxford, UK., Gollins S; North Wales Cancer Treatment Centre, Rhyl, UK., Wasan HS; Hammersmith Hospital, Imperial College London, London, UK., Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Apr; Vol. 19 (4), pp. 562-578.
Autor:
James RD; The Kent Cancer Centre, Maidstone, UK., Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2013 May; Vol. 14 (6), pp. 516-24. Date of Electronic Publication: 2013 Apr 09.